- Anixa Biosciences (ANIX, Financial) to hold an investor webcast on June 26, 2025, at 2:00 PM EDT.
- CEO Dr. Amit Kumar to provide insights into business strategy and future milestones.
- Registration required via Zoom link; webcast available on the company's investor relations site.
Anixa Biosciences, Inc. (ANIX), a biotechnology firm dedicated to cancer treatment and prevention, has announced an investor webcast to be conducted on June 26, 2025, at 2:00 PM EDT. The event will feature Dr. Amit Kumar, Chairman and CEO, who will deliver an extensive overview of the company's therapeutic portfolio, business strategy, market opportunities, and anticipated milestones.
The interactive session will also incorporate a Q&A segment, enabling investors to engage directly with the management. Participants are required to pre-register through a specific Zoom link to gain access to the live event. Post-webcast, a recorded version along with presentation materials will be accessible on Anixa's investor relations website.
Anixa Biosciences (ANIX, Financial) is actively developing its ovarian cancer immunotherapy program in collaboration with the Moffitt Cancer Center utilizing CER-T technology. Additionally, the company is advancing its vaccine portfolio in partnership with Cleveland Clinic, targeting breast and ovarian cancers as well as other prevalent malignancies.
